MARSH & MCLENNAN COMPANIES, INC.·4

Mar 5, 5:01 PM ET

Doyle John Q 4

4 · MARSH & MCLENNAN COMPANIES, INC. · Filed Mar 5, 2026

Insider Transaction Report

Form 4
Period: 2026-03-04
Doyle John Q
President and CEO
Transactions
  • Sale

    Common Stock

    [F1]
    2026-03-04$183.30/sh16,655$3,052,862116,811.021 total
  • Exercise/Conversion

    Common Stock

    [F1]
    2026-03-04+16,655133,466.021 total
  • Exercise/Conversion

    Stock Options (Right to Buy)

    [F1][F2]
    2026-03-0416,65549,968 total
    Exercise: $73.19Exp: 2027-02-21Common Stock (16,655 underlying)
Footnotes (2)
  • [F1]This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.
  • [F2]These options were granted on February 22, 2017 and vested in four equal annual installments on February 22nd of 2018, 2019, 2020 and 2021.
Signature
/s/ Tessa Patti, Attorney-in-fact|2026-03-05

Documents

1 file
  • 4
    form4.xmlPrimary

    PRIMARY DOCUMENT